The FDA sometimes grants marketing approval to innovative new devices through a Pre-Market Approval Pathway, or PMA. Under this pathway, companies are allowed to bring their products to market more quickly--with less than optimal evidence on safety and effectiveness--as long as they promise to continue collecting such data through post-market surveillance. According to a study in JAMA, device manufacturers often fail to keep up their side of this bargain.
Read Full Article »
